Defense Advanced Research Projects AgencyTagged Content List

Infectious Disease

Relating to ailments caused by pathogens

Showing 9 results for Disease + Forecasting RSS
04/13/2018
COL Matthew Hepburn joined DARPA as a program manager in 2013. He aims to address the dynamic threats of emerging infectious diseases with potential impact on national security.
01/01/2015
To accelerate the development of new infectious disease forecasting methods, DARPA launched its CHIKV Challenge. The chikungunya virus (CHIKV) first appeared in the Americas in 2013 but was quickly spreading and by mid-2015, the Pan-American Health Organization (PAHO) had tallied close to 1.4 million suspected cases and more than 33,000 confirmed. Spread by mosquitoes, chikungunya is rarely fatal but can cause debilitating joint and muscle pain, fever, nausea, fatigue, and rash, and poses a growing public health and national security risk.
08/14/2014
The Chikungunya virus (CHIKV) is on the move. Spread among humans by mosquitoes, and spread across geographic boundaries by humans who travel, the virus—which causes a debilitating illness—is now expanding through the Western Hemisphere. Governments and health organizations could take proactive steps to limit its spread if they had accurate forecasts of where and when it would appear. DARPA’s CHIKV Challenge asks teams to create models to deliver such forecasts for all of the countries and territories in the Americas and the Caribbean over a six-month period starting in September 2014.
06/13/2016
Imagine the workplace during flu season. Some people get sick and display clear symptoms—a warning sign to coworkers to avoid contact and for that individual to stay home. Others are infected, but never or only belatedly exhibit the tell-tale signs of sickness, meaning they can infect coworkers without knowing it. If healthcare professionals had the ability to test in advance whether a person is likely to spread a disease following infection, they could recommend specific measures to treat the person or limit exposure and perhaps keep an outbreak from growing into an epidemic or pandemic.
05/14/2020
In this episode of our Voices from DARPA podcast, Eric Van Gieson, a program manager since 2017 in the agency’s Biological Technologies Office (BTO), recounts how a boyhood fascination with DARPA ultimately led to his current role overseeing a portfolio of envelope-pushing programs. These include a program that seeks new diagnostic tools for perhaps the earliest-possible detection of exposure to pathogens, including SARS-CoV-2, the virus that causes COVID-19; an effort to identify and leverage the biomolecular bases underlying optimal performance in such roles as piloting aircraft or participating in special forces missions; research toward new personal-protection technologies that combine advanced featherweight fabrics with designed, bio-based agents applied directly to the body where they can neutralize injurious chemical and biological agents before they can do damage; and a bold biomedical strategy that stands a chance of replacing some medicine-based treatments (for conditions ranging from irritable bowel syndrome to post-traumatic stress disorder) with treatments based on the electrical stimulation of the peripheral nervous system, specifically the far-reaching vagus nerve.